February 1, 2024 · Form 4 insider transaction
Kemps-Polanco Reshema bought 170 shares of Charles River Laboratories International, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Consists of 170 unvested restricted stock units that vest on 5/7/2024.